Jia, X., Wang, K., Wang, X., Luo, Y., Liu, H., Zhao, Z., . . . Li, M. (2025). Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients. Therapeutic Advances in Medical Oncology, 17, . https://doi.org/10.1177/17588359251336623
Chicago-referens (17:e uppl.)Jia, Xiaomeng, Kainan Wang, Xueqing Wang, Yiyang Luo, Huixin Liu, Zuowei Zhao, Jinbo Zhao, och Man Li. "Options After Progression on First-line CDK4/6 Inhibitors in Advanced Breast Cancer Patients." Therapeutic Advances in Medical Oncology 17 (2025). https://doi.org/10.1177/17588359251336623.
MLA-referens (9:e uppl.)Jia, Xiaomeng, et al. "Options After Progression on First-line CDK4/6 Inhibitors in Advanced Breast Cancer Patients." Therapeutic Advances in Medical Oncology, vol. 17, 2025, https://doi.org/10.1177/17588359251336623.
